Auñón, Á.; Tovar-Bazaga, M.; Blanco-García, A.; García-Cañete, J.; Parrón, R.; Esteban, J.
Does a New Antibiotic Scheme Improve the Outcome of Staphylococcus aureus-Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)? Antibiotics 2022, 11, 922.
https://doi.org/10.3390/antibiotics11070922
AMA Style
Auñón Á, Tovar-Bazaga M, Blanco-García A, García-Cañete J, Parrón R, Esteban J.
Does a New Antibiotic Scheme Improve the Outcome of Staphylococcus aureus-Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)? Antibiotics. 2022; 11(7):922.
https://doi.org/10.3390/antibiotics11070922
Chicago/Turabian Style
Auñón, Álvaro, Miguel Tovar-Bazaga, Antonio Blanco-García, Joaquín García-Cañete, Raúl Parrón, and Jaime Esteban.
2022. "Does a New Antibiotic Scheme Improve the Outcome of Staphylococcus aureus-Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)?" Antibiotics 11, no. 7: 922.
https://doi.org/10.3390/antibiotics11070922
APA Style
Auñón, Á., Tovar-Bazaga, M., Blanco-García, A., García-Cañete, J., Parrón, R., & Esteban, J.
(2022). Does a New Antibiotic Scheme Improve the Outcome of Staphylococcus aureus-Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)? Antibiotics, 11(7), 922.
https://doi.org/10.3390/antibiotics11070922
